Tratamiento endocrinológico de la endometriosis

Olive DL. Diagnosis and Management of Endometriosis. En: Carr BR, Blackwell RE (Eds.). Textbook of Reproductive Medicine. Appleton & Lange. Norwalk, Connecticut, USA. 1993; 645.

Barbieri RL. Use of GnRH agonists in endometriosis. Infertil Reprod. Med. Clin. North. Am. 1993; 4: 21.

Dlugi AM, Rufo S, D’Amico JF, et al. A comparison of the effects of buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis. Fértil Steril 1988; 49: 913.

Barbieri RL. Hormonal therapy of endometroisis. Infertil Reprod. Med. Clin. North. Am. 1992; 3: 187.

Buttram VC, Reiter RC, Ward S. Treatment of endometriosis with danazol: report of a 6-year prospective study. Fértil Steril 1985; 43: 353.

Buttram VC. Evolution of the revised American Fertility Society Classification of Endometriosis. Fértil Steril 1985; 43: 347.

Dmowski WP, Tummon I, Radwanska E, et al. Ovarian suppression in the management of endometriosis: a randomized, comparative study. Fértil Steril 1989; 51: 395.

Kiesel L, Runnebaum B. Mechanisms Involved in the Hormonal Treatment of Endometriosis. En: Chadha DR, Buttram VC (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 179.

Brosens IA. The rationale for endocrine therapy. Acta Obstet. Gynecol. Scand. (Suppl). 1989; 150: 21.

Kauppila AJI, Telimaa S, Ronnber L. Steroidal drugs in endometriosis. Acta Obstet. Gynecol. Scand. (Suppl). 1989; 150: 7.

Dmowski P, Rilland R, Schweppe K-W. Endometriosis. Editado por Hoechst. Munich, Alemania. 1989.

Moghissi KS. Pseudopregnancy Induced by Estrogen-progestogen or Progestogens Alone in the Treatment of Endometriosis. En: Chadha DR, Buttram VC Jr. (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 221.

Dawood MY. Considerations in selecting appropriate medical therapy for endometriosis. Int. J. Gynecol. Obstet. 1993; 40(Suppl): S29.

Hurst BS, Schlaff WD. Treatment options for endometriosis. Medical therapies. Infertil Reprod. Med. Clin. North. Am. 1992; 3: 645.

Rosen GF. Treatment of endometriosis-associated infertility. Infertil Reprod. Med. Clin. North. Am. 1992; 3: 721.

Luciano AA, Turksoy RN, Carleo J. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet. Gynecol. 1988; 72: 323.

Coutinho EM. Therapeutic Experience with Gestrinone. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 233.

Thomas EJ, Cooke ID. Impact of gestrinone on the course of asymptomatic endometriosis. Br. Med. J. 1987; 294: 272.

Venturini PL, Bertolini S, Brunenghi MCM, et al. Endocrine, metabolic and clinical effects of gestrinone in women with endometriosis. Fértil Steril 1989; 52: 589.

Cooke ID, Thomas EJ. The medical treatment of mild endometriosis. Acta Obstet. Gynecol. Scand. (Suppl) 1989; 150: 27.

Thomas EJ. Preventive, Symptomatic and Expectant Management of Endometriosis. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 197.

Donnez J, Nisolle M, Clerckx F, Casanas F. Evaluation of Preoperative Use of Danazol, Gestrinone, Lynestrenol, Buserelin Spray and Buserelin Implant, in the Treatment of Endometriosis Associated Infertility. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog Clin Biol Res 1990; 323:427.

Mettler L. Pathogenesis, diagnosis and treatment of genital endometriosis. Acta Obstet. Gynecol. Scand. (Suppl) 1989; 150: 31.

Barbieri RL. Danazol: Molecular, Endocrine, and Clinical Pharmacology. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 241.

Maouris P, Dowsett M, Rose G, et al. A new treatment for endometriosis. The Lancet 1989: 1018.

Trabant H, Widdra W, de Looze S. Efficacy and Safety of Intranasal Buserelin Acetate in the Treatment of Endometriosis: a Review of Six Clinical Trials and Comparison with Danazol. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog Clin Biol Res 1990; 323: 357.

Chong A, Keene ME, Thornton NL. Comparison of three modes of treatment for infertility patients with minimal pelvic endometriosis. Fértil Sterii 1990; 53:407.

Rosenfield RL, Jacob J. Subsequent pregnancies in previously infertile women with endometriosis. Obstet. Gynecol. 1988; 72: 908.

El-Roeiy A, Dmowski WP, Gleicher N, et al. Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fértil Sterii 1988; 50: 864.

Gleicher N, Pratt D. Abnormal (auto) immunity and endometriosis. Int J Gynecol. Obstet. 1993, 40(Suppl): S21.

Calaf J. Análogos de la GnRH: pasado, presente y futuro. Drugs of Today 1990; 26(Supl. 5): 1.

Henzl MR. Hormona liberadora de gonadotropinas y sus análogos: del laboratorio a la cabecera. Clin. Obstet. Ginecol. 1993; 3: 588.

Handelsman DJ, Swerdloff RS. Pharmacokinetics of gonadotropinreleasing hormone and its analogs. Endocrine Rev 1986; 7: 95.

Karten M, Rivier JE. Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocrine Rev 1986; 7: 44.

Hazum E, Conn M. Molecular mechanism of gonadotropin releasing hormone (GnRH) action. I. The GnRH receptor. Endocrine Rev 1988; 9: 379.

Bhasin S, Swerdloff RS. Mechanisms of gonadotropin-releasing hormone agonist action in the human male. Endocrine Rev 1986; 7: 106.

Jaakkola T, Ding Y-Q, Kellokumpu-Lehtinen P. The ratios of serum bioactive/immunoactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay. J Clin Endocrinol Metab 1990; 70: 1496.

Steingold KA, Cedars M, LH JKH, et al. Treatment of endometriosis with a long acting gonadotropin-releasing hormone agonist. Obstet. Gynecol. 1987; 69: 403.

Lemay A, Bergeron J, Sandow J, et al. Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist. Fértil Sterii 1988; 49: 802.

Corbin A, Bex FJ, Jones RC. Comparison of LHRH agonist and antagonist: antifertility and therapeutic developments. En: Labrie F, Belanger A, Dupont A (Eds.). LHRH and its analogues. Elsevier Science Publishers BV. 1984; 95.

Lemay A, Maheux R, Faure N, et al. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fértil Sterii 1984; 41: 863.

Neyro JL. Miscelánea: indicaciones, alternativas y otros usos de los análogos LH-RH. Drugs of Today 1990; 26(Supl. 5): 37.

Miller JD. Leuprolide acetate for the treatment of endometriosis. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 337.

Shaw RW. Goserelin-Depot preparation of LHRH analogue used in the treatment of endometriosis. En Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 383.

Barbieri RL. Agonistas de la hormona liberadora de gonadotropinas: tratamiento de la endometriosis. Clin. Obstet. Ginecol. 1993; 3: 606.

Ordáz J, Pérez-Piñar. Análogos de LH-RH en el tratamiento de la endometriosis. Drugs of Today 1990; 26(Supl. 5): 11.

Zom J-R, Risquez F, Comaru-Schally, Schally AV. Treatment of endometriosis with a delayed release preparation of the agonist D-trp6- Muteinizing hormone-releasing hormone: long-term follow-up in a series of 50 patients. Fértil Sterii 1990; 53: 401.

Weise HC, Fiedler K, Kato K. Buserelin suppresion of endogenous gonadotropin secretion in infertile women with ovarian feedback disorders given human menopausal/human chorionic gonadotropin treatment. Fértil Sterii 1988; 49: 399.

Scriock E, Monroe SE, Henzl M, et al. Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)*. Fértil Sterii 1985; 44: 583.

Damewood M, Schlaff WD, Hesla JS, Rock JA. Interval bone mineral density with long term gonadotropin-releasing hormone agonist suppression. Fértil Steril 1989; 52: 596.

Tummon IS, Radwanska E, Ali A, et al. Bone mineral density in women with endometriosis before and during ovarian suppresion with gonadotropin-releasing hormone agonists or danazol. Fértil Steril 1988; 49: 792.

Henzl MR, Monroe SE. Nafarelin: a new medical therapy for endometriosis. En: Chadha DR, Buttram VC Jr (Eds.). Current Concepts in Endometriosis. Prog. Clin. Biol. Res. 1990; 323: 343.

Fogelman I. Gonadotropin-releasing hormone agonists and the skeleton. Fértil Steril 1992; 57: 715.

Dawood MY, Lewis V, Ramos J. Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin releasing hormone agonist and danazol. Fértil Steril 1989; 52: 21.

Henzl MR, Corson SL, Moghissi K, et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis: A multicenter double-blind comparative trial. N. Engl. J. Med. 1988; 318: 485.

Nisolle M, Paindaveine B, Bourdon A, et al. Histologic study of peritoneal endometriosis in infertile women. Fértil Steril 1990; 53: 984.

Murphy AA, Green WR, Bobbie D, et al. Unsuspected endometriosis documented by scanning electron microscopy in visually normal peritoneum. Fértil Steril 1986; 46: 522.

Malinak LR. Surgical treatment and adjunct therapy of endometriosis. Int. J. Gynecol. Obstet. 1993; 40(Suppl): S43.

Simón C. Endometriosis. El futuro. En: Simón C, Nezhat C. (Ed). Cuadernos de Medicina Reproductiva. Volumen 1, No. 2. Endometriosis. Editorial Panamericana, Madrid, España. 1995.